2 withdrawn. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Withdrawn 2 |
Follow SARS-CoV-2: new trials by email Literature Review of SARS-CoV-2 trials Research Report on SARS-CoV-2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Zambia Ivermectin Trial for the Treatment and Prevention of COVID-19 Ivermectin, Prophylaxis - SARS-CoV-2, Ivermectin | Phase 4 | Withdrawn | Centre for Infectious Disease Research in Zambia | 2021-10-01 | 2022-02-03 | |
| Use of Dexmedetomidine in Light to Moderate Sedation in the Patient in the Palliative Situation of a Sars-cov-2 / COVID-19 Infection Treatment with Dexmedetomidine - COVID-19 Infection, Sars-cov-2 | Phase 4 | Withdrawn | University Hospital, Limoges | 2020-04-20 | 2020-09-02 |
COVID-19 (1) · Infections (1) · Respiratory Insufficiency (1)
Coronaviridae Infections (1) · Coronavirus Infections (1) · Lung Diseases (1) · Nidovirales Infections (1) · Pneumonia (1) · Pneumonia, Viral (1) · RNA Virus Infections (1) · Respiration Disorders (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1) · Virus Diseases (1)
Dexmedetomidine (1) · Ivermectin (1) · Therapeutics (1)
Centre for Infectious Disease Research in Zambia (1) · University Hospital, Limoges (1)
France (1) · Zambia (1)